Teva Pharmaceutical Industries Ltd financial data

Symbol
TEVA on NYSE, TEVJF on OTC
Location
Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi'a St., Tel Aviv, Israel
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 98.8 % +4.23%
Quick Ratio 27.6 % -12.5%
Debt-to-equity 548 % +9.85%
Return On Equity -2.54 % +58.3%
Return On Assets -0.4 % +62.9%
Operating Margin 5.38 % -0.19%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.15B shares +1.26%
Entity Public Float 18.3B USD +119%
Common Stock, Value, Issued 58M USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.15B shares +1.24%
Weighted Average Number of Shares Outstanding, Diluted 1.16B shares +2.47%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16.6B USD +2.08%
Selling and Marketing Expense 2.55B USD +4.16%
General and Administrative Expense 1.2B USD +7.32%
Operating Income (Loss) 894M USD +1.94%
Nonoperating Income (Expense) -967M USD +5.2%
Income Tax Expense (Benefit) 94M USD -84.5%
Net Income (Loss) Attributable to Parent -158M USD +65%
Earnings Per Share, Basic 0 USD/shares +64.1%
Earnings Per Share, Diluted 0 USD/shares +59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.16B USD -4.3%
Accounts Receivable, after Allowance for Credit Loss, Current 3.56B USD -5.36%
Inventory, Net 3.5B USD -11%
Other Assets, Current 472M USD -8.7%
Assets, Current 12.6B USD +8.49%
Deferred Income Tax Assets, Net 1.78B USD -11%
Property, Plant and Equipment, Net 4.81B USD -13.7%
Operating Lease, Right-of-Use Asset 358M USD 0%
Goodwill 15.9B USD -3.27%
Other Assets, Noncurrent 470M USD +8.3%
Assets 40.1B USD -2.92%
Accounts Payable, Current 158M USD +46.3%
Employee-related Liabilities, Current 481M USD -2.24%
Liabilities, Current 11.9B USD -9.02%
Operating Lease, Liability, Noncurrent 296M USD +5.34%
Other Liabilities, Noncurrent 3.94B USD -9.6%
Liabilities 33.3B USD -4.25%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.43B USD +15.6%
Retained Earnings (Accumulated Deficit) -14.7B USD -1.08%
Stockholders' Equity Attributable to Parent 6.83B USD +7.36%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.83B USD +4.13%
Liabilities and Equity 40.1B USD -2.92%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.39B USD +19%
Net Cash Provided by (Used in) Financing Activities -2.41B USD -6.3%
Net Cash Provided by (Used in) Investing Activities 907M USD +12.4%
Common Stock, Shares Authorized 2.5B shares 0%
Common Stock, Shares, Issued 1.25B shares +1.13%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -96M USD +76.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.16B USD -4.3%
Deferred Tax Assets, Valuation Allowance 2.02B USD -33%
Deferred Tax Assets, Gross 1.8B USD -0.72%
Operating Lease, Liability 383M USD -8.15%
Payments to Acquire Property, Plant, and Equipment 119M USD -6.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 293M USD
Lessee, Operating Lease, Liability, to be Paid 495M USD -0.2%
Property, Plant and Equipment, Gross 8.99B USD -21%
Operating Lease, Liability, Current 296M USD -7.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 102M USD +4.08%
Lessee, Operating Lease, Liability, to be Paid, Year One 120M USD +3.45%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 81M USD +1.25%
Unrecognized Tax Benefits 449M USD -31%
Lessee, Operating Lease, Liability, to be Paid, Year Four 57M USD -8.07%
Additional Paid in Capital 28B USD +0.63%
Amortization of Intangible Assets 583M USD -0.68%